Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Lung Diseases 1

Interventions

Carboplatin 349 pembrolizumab 327 Pemetrexed 249 Cisplatin 220 Paclitaxel 150 Nivolumab 140 durvalumab 135 Docetaxel 112 osimertinib 110 atezolizumab 106 Specimen Handling 92 Radiotherapy 87 Drug Therapy 87 Magnetic Resonance Spectroscopy 78 Etoposide 77 Radiosurgery 72 Gemcitabine 72 Ipilimumab 56 130-nm albumin-bound paclitaxel 54 Bevacizumab 53 cemiplimab 47 tislelizumab 46 Blood Specimen Collection 43 Taxes 36 Cetuximab 34 Biopsy 33 Standard of Care 32 Platinum 32 Injections 32 Immunoglobulin G 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

One-Lung Ventilation × Thoracic × 1 year × Clear all

NCT00534690 2026-05-15

REVOLU

University Hospital, Bordeaux

Phase NA Completed

Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡